首页 | 本学科首页   官方微博 | 高级检索  
     

50例晚期胰腺癌三维适形放疗的近期疗效分析
引用本文:王凤玮,尹晓东,刘兴强,王新卓,张龙,周培,张明增,王建华,江涛. 50例晚期胰腺癌三维适形放疗的近期疗效分析[J]. 中华肝胆外科杂志, 2010, 16(3). DOI: 10.3760/cma.j.issn.1007-8118.2010.03.005
作者姓名:王凤玮  尹晓东  刘兴强  王新卓  张龙  周培  张明增  王建华  江涛
作者单位:1. 天津市人民医院放疗科,300130
2. 天津市人民医院消化外科,300130
摘    要:
目的 分析三维适形放疗治疗晚期胰腺癌的疗效及相关预后因素.方法 50例不能手术的晚期胰腺癌病人,采用常规分割的三维适形放疗;其中14例采用姑息性放疗(A组),给予10.8~56 Gy;27例采用单一三维适形放疗(B组),剂量范围为8~60.5 Gy;9例采用同步放化疗的方法(C组),剂量范围为10~64 Gy.同步放化疗中化疗采用吉西他滨(200~600 mg/m~2,1次/周).结果 随访时间为3~35个月,死亡43例,死亡原因主要为肝脏和(或)腹腔内的广泛转移、恶液质、继发感染和出血.存活7例中3例为同步放化疗,3例为单一放疗,1例为姑息治疗.A组存活1人,放疗后局部症状缓解率46%(6/13),平均生存时间5.07个月;其中放疗剂量小于45 Gy的病人有10例,平均存活时间为4.33个月;放疗剂量≥45 Gy者3例,平均存活时间为7.33个月.B组存活3例,治疗后疼痛缓解率为81%(22/27),平均存活6.65个月,其中放疗剂量小于45 Gy的有11例,平均存活时间为4.36个月;放疗剂量≥45 Gy者16例,平均存活时间为8.33个月.C组存活3例,治疗后疼痛缓解率为89%(8/9),放疔后平均存活9.89个月,其中放疗剂量小于45 Gy的有1例,存活时间为3个月;放疗剂量≥45 Gy者8例,平均存活时间为10.73个月.结论 三维适形放疗对晚期胰腺癌有姑息治疗的作用,疗效与治疗方式的选择、放疗剂量、病变累及范围和病人一般状态密切相关.对于部分晚期胰腺癌病人,采用积极同步放化三维适形放疗可获得较长的生存时间.

关 键 词:胰腺肿瘤  同步放化疗  三维适形放疗

Analysis of short-term efficacy of 3D conformal radiotherapy for late-stage pancreatic cancer
WANG Feng-wei,YIN Xiao-dong,LIU Xing-qiang,WANG Xin-zhuo,ZHANG Long,ZHOU Pei,ZHANG Ming-zeng,WANG Jian-hua,JIANG Tao. Analysis of short-term efficacy of 3D conformal radiotherapy for late-stage pancreatic cancer[J]. Chinese Journal of Hepatobiliary Surgery, 2010, 16(3). DOI: 10.3760/cma.j.issn.1007-8118.2010.03.005
Authors:WANG Feng-wei  YIN Xiao-dong  LIU Xing-qiang  WANG Xin-zhuo  ZHANG Long  ZHOU Pei  ZHANG Ming-zeng  WANG Jian-hua  JIANG Tao
Abstract:
Objective To investigate the efficacy of 3D conformal radiotherapy for late-stage pancreatic cancer and determine relavent prognostic factors.Methods Fifty patients with advanced pancreatic cancer were divided into 3 groups according to treatment planning: palliative radiotherapy (group A) at 10.8-56 Gy, radiotherapy alone (group B) at 8-60.5 Gy and concurrent chemoradiother-apy (group C) at 10-64 Gy.All patients received 3D-conformal radiotherapy, and smaller multiple ports were used for palliative treatment whereas large fields including pancreatic tumors and adjacent lymph node drainage system were adopted in the beginning of radiotherapy.Concurrent chemotherapy with gemcitabine (200-600 mg/m~2) alone was used with weekly protocol.Results The duration of follow-up was 3-35 months.Forty three patients died during the follow-up for multiple metastasis, de-teriation, secondary infection and hemorrhage.Among the seven surviving patients, 3 received concur-rent radiotherapy, 3 radiotherapy alone and 1 palliative radiotherapy.Only 1 patient was alive in group A.However, the symtoms were relieved in 46% of the patients.The median survival time was 5.07 months whereas it was 4.33 months for patients received less than 45 Gy and 7.33 months for patients received 45 Gy or more.Three patients were alive in group B and the symptoms were relieved in 81% of the patients.The median survival time was 6.65 months whereas it was 4.36 months for patients received less than 45 Gy and 8.33 months for patients received 45 Gy or more.Three patients were a-live in group C and the symptoms were relieved in 89% of the patients.The median survival time was 9.89 months.One patient survived for 3 months after 8 Gy irradiation.The median survival time was 10.73 months for patients received 45 Gy or more.Conclusion 3D-conformal radiotherapy is safe and effective in treatment of advanced pancreatic cancer.The symptom relieving rate and median survival time seem to be related to patient's status, extent of disease, choice of treatment and irradiation dos-age.3D-confromal concurrent chemoradiotherapy leads to the longest survival time in some patients.
Keywords:Pancreatic neoplasms  Concurrent chemoradiotherapy  3D-conformal radiotherapy
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号